Gastro-intestinal Quality of Life After Metabolic Surgery for the Treatment of Type 2 Diabetes Mellitus

Abstract

Background

Emerging evidence has shown that bariatric/metabolic surgery ameliorates type 2 diabetes (T2DM) in mildly obese patients (BMI < 35 kg/m2) but long-term data is inadequate. We investigated the change of the quality of life after metabolic surgery in not well-controlled T2DM patients with BMI < 35 kg/m2.

Methods

The quality of life was measured by the gastrointestinal quality of life index (GIQLI), a 36-item questionnaire divided into three domains of general health and one domain of specific gastro-intestinal symptoms, administered before operation, at 3, 6, and 12 months after surgery. A control group matched in age, gender, and BMI was recruited for comparison.

Results

A total of 86 patients were enrolled, and the preoperative BMI and HbA1C (mean ± SD) were 30.7 ± 2.8 kg/m2 and 9.3 ± 2.1 %, respectively. At 1 year after surgery, the BMI and HbA1C were 24.3 ± 2.3 kg/m2 and 6.2 ± 1.1 %, respectively. There was a significantly improvement in all of the measures of glucose metabolism. Complete remission (HbA1C < 6.0 %) was achieved in 56 subjects (65 %) at 12 months. The GIQLI score was significantly impaired in T2DM patients before surgery compared with the control group. The GIQLI score significantly increased from 109.2 ± 20.0 to 116.1 ± 14.2 points 1 year after surgery. The patients had improvement in the three domains of general health (social, physical, and emotional function) without a difference with the normal control but deteriorated in the domain of specific symptoms. Most of the patients experienced symptoms including abdominal pain, bloating, flatulence, belching, abdominal noise, regurgitation, dysphagia, slow eating speed, nausea, bowel urgency, and incontinence after metabolic syndrome.

Conclusions

Health-related QOL improved dramatically after metabolic surgery for not well-controlled T2DM patients with BMI < 35 kg/m2, but patients might develop specific gastro-intestinal symptoms after surgery.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2

References

  1. 1.

    Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world—a growing challenge. N Engl J Med. 2007;356:213–5.

    CAS  PubMed  Article  Google Scholar 

  2. 2.

    Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129–40.

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Stark Casagrande S, Fradkin JE, Saydah SH, et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1998–2010. Diabetes Care. 2013;36(8):2271–9.

    PubMed Central  PubMed  Article  Google Scholar 

  4. 4.

    Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–58.

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. NEJM. 2004;351:2683–93.

    PubMed  Article  Google Scholar 

  7. 7.

    Dixon J, O’Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabete Care. 2002;25:358–63.

    Article  Google Scholar 

  8. 8.

    Karlsson J, Taft C, Ryden A, et al. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond). 2007;31:1248–61.

    CAS  Article  Google Scholar 

  9. 9.

    Chang CY, Huang CK, Chang YY, et al. Prospective study of health-related quality of life after Roux-en-Y bypass surgery for morbid obesity. Br J Surg. 2010;97:1541–6.

    PubMed  Article  Google Scholar 

  10. 10.

    Lee WJ, Wang W, Lee YC, et al. Effects of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg. 2008;12:945–52.

    PubMed  Article  Google Scholar 

  11. 11.

    Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit Consensus Conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251:399–405.

    PubMed  Article  Google Scholar 

  12. 12.

    Dixon JB, OBrien PE. Play fair I. et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: I ramdomized controlled trial. JAMA 2008 299:316–323

  13. 13.

    Schauer PR, Kashyap S, Wolski K. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  14. 14.

    Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. The Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309:2240–9.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  15. 15.

    Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013;309(21):2250–61.

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Lebovitz HE. Metabolic surgery for type 2 diabetes with BMI <35 kg/m2. An endocrinologist’s perspective. Obes Surg. 2013;23:800–8.

    PubMed Central  PubMed  Article  Google Scholar 

  17. 17.

    Sjostrom L, Narbro K, Sjostrom D, et al. Effect of bariatric surgery on mortality in Swedish obese subjects. NEJM. 2007;357:741–52.

    PubMed  Article  Google Scholar 

  18. 18.

    Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 Suppl 1:S62-9.

  19. 19.

    Lee WJ, Yu PY, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242:20–8.

    PubMed Central  PubMed  Article  Google Scholar 

  20. 20.

    Ser K-H, Lee W-J, Lee Y-C, et al. Experience in laparoscopic sleeve gastrectomy for morbid obese Taiwanese: staple-line reinforcement is important for preventing leakage. Surg Endosc. 2010;24:2253–9.

    PubMed  Article  Google Scholar 

  21. 21.

    Espasch E, Williams JL, Wood-Dauphinee S. Gastrointestinal Quality of Life Index: development validation and application of new instrument. Br J Surg. 1995;82:216–22.

    Article  Google Scholar 

  22. 22.

    Jentschura D, Winkler M, Strohmeier N, et al. Quality-of-life after curative surgery for gastric cancer: a comparison between total gastrectomy and subtotal gastric resection. Hepatogastroenterology. 1997;44:1137–42.

    CAS  PubMed  Google Scholar 

  23. 23.

    Slim K, Bousquet J, Kwiatkowski F. Quality of life before and after laparoscopic fundoplication. Am J Surg. 2001;180:41–5.

    Article  Google Scholar 

  24. 24.

    Decker G, Borie F, Bouamrirene D. Gastrointestinal quality of life before and after laparoscopic Heller myotomy with partial posterior fundoplication. Ann Surg. 2002;236:750–8.

    PubMed Central  PubMed  Article  Google Scholar 

  25. 25.

    Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity. Ann Surg. 2005;242:20–8.

    PubMed Central  PubMed  Article  Google Scholar 

  26. 26.

    Lee WJ, Wang W, Yu PJ, et al. Gastrointestinal quality of life following laparoscopic adjustable gastric banding in Asia. Obes Surg. 2006;16:586–91.

    PubMed  Article  Google Scholar 

  27. 27.

    Peterli R, Wolnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg. 2009;250:234–41.

    PubMed  Article  Google Scholar 

  28. 28.

    Overs SE, Freeman RA, Zarshenas N, et al. Food tolerance and gastrointestinal quality of life following three bariatric procedures: adjustable gastric banding, Roux-en-Y gastric bypass, and sleeve gastrectomy. Obes Surg. 2012;22:536–43.

    PubMed  Article  Google Scholar 

  29. 29.

    Lee YC, Liew PL, Lee WJ, et al. Gastrointestinal quality of life following bariatric surgery in Asian patients. Hepatogastroenterology. 2013;60:759–61.

    PubMed  Google Scholar 

  30. 30.

    Yu PJ, Tsou JJ, Lee WJ, et al. Impairment of gastrointestinal quality of life in severely obese patients. World J Gastroenterol. 2014;20:7027–33.

    PubMed Central  PubMed  Article  Google Scholar 

  31. 31.

    Buse JB, Laughlin S, Caprio S, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133–5.

    PubMed Central  PubMed  Article  Google Scholar 

  32. 32.

    Wandell PE, Brorsson B, Aberg H. Quality of life in diabetic patients registered with primary health care services in Sweden. Scand J Prim Health Care. 1997;15:97–102.

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Rev. 1999;15(3):205–18.

    CAS  Article  Google Scholar 

  34. 34.

    McEwen LN, Kim C, Haan MN, et al. Are health-related quality-of-life and self-rated health associated with mortality? Insights from Translating Research Into Action for Diabetes (TRIAD). Prim Care Diabetes. 2009;3(1):37–42.

    PubMed Central  PubMed  Article  Google Scholar 

  35. 35.

    Landman GW, van Hateren KJ, Kleefstra N, et al. Health-related quality of life and mortality in a general and elderly population of patients with type 2 diabetes (ZODIAC-18). Diabetes Care. 2010;33(11):2378–82.

    PubMed Central  PubMed  Article  Google Scholar 

  36. 36.

    Kleefstra LGW, Houweling ST, et al. Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4). Diabetes Care. 2008;31(5):932–3.

    PubMed  Article  Google Scholar 

  37. 37.

    Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes. N Engl J Med. 2014. doi:10.1056/NEJMoa1401329.

  38. 38.

    Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care. 1994;17(4):267–74.

    CAS  PubMed  Article  Google Scholar 

  39. 39.

    Treif PM, Grant W, Elbert K, et al. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care. 1997;20:299–305.

    Article  Google Scholar 

  40. 40.

    Ahroni JH, Boyko EJ, Davignon DR, et al. The health and functional status of veterans with diabetes. Diabetes Care. 1994;17:318–21.

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Wuslin LR, Jacobson AM, Rand LI. Psychosocial aspects of diabetic retinopathy. Diabetes are. 1998;21:1699–706.

    Google Scholar 

  42. 42.

    Hanestand BR, Gruce M. To maintain quality of life and satisfactory metabolic control in type II diabetes patients. Qual Life Res. 1995;4:436–7.

    Google Scholar 

  43. 43.

    Wikblad K, Leksell J, Wibell L. Health-related quality of life in relationship to metabolic control and late complication in patients with insulin dependent diabetes mellitus. Quality of life Res. 1996;5:123–30.

    CAS  Article  Google Scholar 

  44. 44.

    Peterson T, Lee P, Young B, et al. Well-being and treatment satisfaction in older people with diabetes. Diabetes Care. 1998;21:930–5.

    Article  Google Scholar 

  45. 45.

    Keinanen-Kiukaanniemi S, Ohinmaa A, Pajunpaa H, et al. Health iabet Med. 1996;13:382–8.

    CAS  Google Scholar 

  46. 46.

    Glasgow RE, Ruggero L, Eakin EG, et al. Quality of life and association characteristics in a large national sample of adults with diabetes. Diabetes Care. 1997;20:562–7.

    CAS  PubMed  Article  Google Scholar 

  47. 47.

    Gilden JL, Casia C, Hendryx M, et al. Effects of self-monitoring of blood glucose on quality of life in elderly diabetic patients. J Am Geriatr Soc. 1990;38:511–5.

    CAS  PubMed  Article  Google Scholar 

  48. 48.

    Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146:143–8.

    PubMed  Article  Google Scholar 

  49. 49.

    Jullig M, Yip S, Xu A, et al. Low fetulin-A, retinol binding 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes. PLoS. 2014;9:e96489.

    Article  Google Scholar 

  50. 50.

    Peterli R, Borbely Y, Ker B, et al. Early results of the Swiss multicentre bypass or sleeve study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg. 2013;258:690–5.

    PubMed Central  PubMed  Article  Google Scholar 

  51. 51.

    Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in non-morbidly obese patients: efficacy and change of insulin secretion. Surgery. 2010;147:664–9.

    PubMed  Article  Google Scholar 

Download references

Conflict of Interest

All authors declare that they have no conflict of interest, and the study has not been supported by any grants.

Statement of Informed Consent

Informed consent was obtained from all individual participants included in the study.

Statement of Human and Animal Rights

For this type of study, formal consent is not required.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Wei-Jei Lee.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lee, W., Lee, M., Yu, P. et al. Gastro-intestinal Quality of Life After Metabolic Surgery for the Treatment of Type 2 Diabetes Mellitus. OBES SURG 25, 1371–1379 (2015). https://doi.org/10.1007/s11695-014-1520-7

Download citation

Keywords

  • Type 2 diabetes
  • Metabolic surgery
  • Quality of life
  • Gastro-intestinal symptoms